Cognizant Technology Solutions Corporation
CTSH · NASDAQ
Analyst ratings
buy · 12 ratings
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| July 13, 2026 | Citigroup | Maintains | Neutral | $45.00 |
| July 10, 2026 | Wells Fargo | Maintains | Overweight | $61.00 |
| July 10, 2026 | Baird | Maintains | Neutral | $55.00 |
| June 26, 2026 | TD Cowen | Maintains | Hold | $47.00 |
| June 23, 2026 | Morgan Stanley | Maintains | Equal-Weight | $44.00 |
| June 9, 2026 | Citigroup | Maintains | Neutral | $55.00 |
| June 8, 2026 | Wedbush | Upgrades | Outperform | $70.00 |
| May 15, 2026 | Citigroup | Maintains | Neutral | $51.00 |
| May 6, 2026 | Mizuho | Maintains | Neutral | $68.00 |
| May 1, 2026 | Susquehanna | Maintains | Positive | $88.00 |
| April 30, 2026 | TD Cowen | Maintains | Hold | $62.00 |
| April 30, 2026 | Citigroup | Maintains | Neutral | $58.00 |
| April 30, 2026 | Morgan Stanley | Maintains | Equal-Weight | $63.00 |
| April 30, 2026 | Guggenheim | Maintains | Buy | $80.00 |
| April 30, 2026 | Wells Fargo | Maintains | Overweight | $83.00 |
| April 30, 2026 | Wedbush | Maintains | Neutral | $56.00 |
| April 28, 2026 | JP Morgan | Maintains | Overweight | $74.00 |
| April 22, 2026 | Guggenheim | Maintains | Buy | $85.00 |
| April 13, 2026 | UBS | Maintains | Neutral | $64.00 |
| April 10, 2026 | Baird | Maintains | Neutral | $72.00 |
| April 7, 2026 | Citigroup | Maintains | Neutral | $68.00 |
| March 13, 2026 | TD Cowen | Maintains | Hold | $71.00 |
| February 5, 2026 | TD Cowen | Maintains | Hold | $85.00 |
| February 5, 2026 | RBC Capital | Maintains | Sector Perform | $88.00 |
| February 5, 2026 | Morgan Stanley | Maintains | Equal-Weight | $82.00 |
| January 28, 2026 | Guggenheim | Maintains | Buy | $100.00 |
| January 22, 2026 | Citigroup | Maintains | Neutral | $86.00 |
| January 14, 2026 | Wells Fargo | Maintains | Overweight | $98.00 |
| January 9, 2026 | TD Cowen | Maintains | Hold | $84.00 |
| December 8, 2025 | UBS | Maintains | Neutral | $82.00 |
| October 30, 2025 | JP Morgan | Maintains | Overweight | $92.00 |
| October 30, 2025 | UBS | Maintains | Neutral | $78.00 |
| October 30, 2025 | Wells Fargo | Maintains | Overweight | $87.00 |
| October 30, 2025 | RBC Capital | Maintains | Sector Perform | $82.00 |
| October 21, 2025 | Guggenheim | Maintains | Buy | $85.00 |
AI-driven growth potential vs. uncertain revenue conversion
Cognizant's expanding AI ecosystem — including the integration of Now AI with its AI Multi Accelerator, a deepened partnership with Rubrik, and new AI Trust Services — positions the company to capture growing enterprise AI demand and broaden its client base across large organizations.
Despite AI product investments, the stock has suffered severe selling pressure, dropping over 9% in a single session. Multiple major banks, including Morgan Stanley, Deutsche Bank, and Wells Fargo, have slashed price targets, reflecting skepticism about whether AI initiatives can translate into near-term revenue and margin recovery.
Stock valuation and analyst price target divergence
The consensus among 25+ analysts points to an average 12-month price target of approximately $63.90–$70.41, implying over 43–68% upside from current levels. HSBC maintained a Buy rating with a $68 target, and Wells Fargo held a Buy with a $61 target, signaling confidence in a meaningful recovery.
Morgan Stanley cut its price target to $44 from $63 while maintaining an Equalweight rating, and Citi holds a Neutral with a $45 target — barely above the current price. The wide range of targets ($42–$93) reflects deep uncertainty about the company's near-term trajectory.
Earnings growth sustainability and EPS outlook
Cognizant has demonstrated consistent earnings beats, reporting $1.23 EPS versus the $1.19 consensus estimate in its last quarter — a 3.36% positive surprise. Analysts project a 7.69% year-over-year EPS increase for the next quarter, suggesting the company's fundamentals remain on a solid growth trajectory.
Technical indicators including MACD, ADX, and RSI all signal sell, with momentum deeply in oversold territory. The stock trades well below its key moving averages, and the probability of further price decline is estimated at 78%, raising concerns about whether earnings growth can overcome broader structural and market headwinds.